beta-lapachone has been researched along with Experimental Mammary Neoplasms in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Totten, SP | 1 |
| Im, YK | 1 |
| Cepeda Cañedo, E | 1 |
| Najyb, O | 1 |
| Nguyen, A | 1 |
| Hébert, S | 1 |
| Ahn, R | 1 |
| Lewis, K | 1 |
| Lebeau, B | 1 |
| La Selva, R | 1 |
| Sabourin, V | 1 |
| Martínez, C | 1 |
| Savage, P | 1 |
| Kuasne, H | 1 |
| Avizonis, D | 1 |
| Santos Martínez, N | 1 |
| Chabot, C | 1 |
| Aguilar-Mahecha, A | 1 |
| Goulet, ML | 1 |
| Dankner, M | 1 |
| Witcher, M | 1 |
| Petrecca, K | 1 |
| Basik, M | 1 |
| Pollak, M | 1 |
| Topisirovic, I | 1 |
| Lin, R | 1 |
| Siegel, PM | 1 |
| Kleinman, CL | 1 |
| Park, M | 1 |
| St-Pierre, J | 1 |
| Ursini-Siegel, J | 1 |
1 other study available for beta-lapachone and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Electron Transpo | 2021 |